{"id":10201,"date":"2016-09-28T15:01:38","date_gmt":"2016-09-28T19:01:38","guid":{"rendered":"http:\/\/canadiantaskforce.ca\/?page_id=10201&#038;lang=fr"},"modified":"2024-04-16T10:11:58","modified_gmt":"2024-04-16T14:11:58","slug":"cancer-colorectal-tableau-de-recommandations","status":"publish","type":"page","link":"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-colorectal-tableau-de-recommandations\/","title":{"rendered":"Cancer Colorectal\u2014Tableau de recommandations"},"content":{"rendered":"<div class='fullwidth-section  ' style=\"background-repeat:no-repeat;background-position:left top;\"><div class=\"container\"><div class=\"dt-sc-tabs-vertical2-container\"><span class=\"dt-sc-tabs-vertical2-frame\"><ul>\n<li class=\"page_item page-item-31718\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/bcu-algorithm\/\">BCU Algorithm Fr<\/a><\/li>\n<li class=\"page_item page-item-31762\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/bcu-demo-fr\/\">BCU Demo Fr<\/a><\/li>\n<li class=\"page_item page-item-22397\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-sein-mise-a-jour-outil-daide-a-la-prise-de-decision-partagee-personnes-agees-de-50-a-59-ans\/\">Cancer du sein (mise \u00e0 jour) (2018)\u2014Outil d\u2019aide a\u0300 la prise de de\u0301cision partag\u00e9e, personnes \u00e2g\u00e9es de 50 a\u0300 59 ans<\/a><\/li>\n<li class=\"page_item page-item-22404\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-sein-mise-a-jour-outil-daide-a-la-prise-de-decision-partagee-personnes-agees-de-60-a-69-ans\/\">Cancer du sein (mise \u00e0 jour) (2018)\u2014Outil d\u2019aide a\u0300 la prise de de\u0301cision partag\u00e9e, personnes \u00e2g\u00e9es de 60 a\u0300 69 ans<\/a><\/li>\n<li class=\"page_item page-item-22410\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-sein-mise-a-jour-outil-daide-a-la-prise-de-decision-partagee-personnes-agees-de-70-a-74-ans\/\">Cancer du sein (mise \u00e0 jour)\u2014Outil d\u2019aide a\u0300 la prise de de\u0301cision partag\u00e9e, personnes \u00e2g\u00e9es de 70 a\u0300 74 ans<\/a><\/li>\n<li class=\"page_item page-item-32057\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/prevention-du-mesusage-des-opioides-et-des-prejudices-associes-aux-opioides\/\">Pr\u00e9vention du m\u00e9susage des opio\u00efdes et des pr\u00e9judices associ\u00e9s aux opio\u00efdes<\/a><\/li>\n<li class=\"page_item page-item-25125\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/public-2\/\">Public<\/a><\/li>\n<li class=\"page_item page-item-11221\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/bulletins\/\">Bulletins<\/a><\/li>\n<li class=\"page_item page-item-19850\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/evaluation-annuelle-2018\/\">\u00c9valuation annuelle 2018<\/a><\/li>\n<li class=\"page_item page-item-24021\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/evaluation-annuelle-2019\/\">\u00c9valuation annuelle 2019<\/a><\/li>\n<li class=\"page_item page-item-24027\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/evaluation-annuelle-2020\/\">\u00c9valuation annuelle 2020<\/a><\/li>\n<li class=\"page_item page-item-25669\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/evaluation-annuelle-2021\/\">\u00c9valuation annuelle 2021<\/a><\/li>\n<li class=\"page_item page-item-31401\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/evaluation-annuelle-2022\/\">\u00c9valuation annuelle 2022<\/a><\/li>\n<li class=\"page_item page-item-31402\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/evaluation-annuelle-2023\/\">\u00c9valuation annuelle 2023<\/a><\/li>\n<li class=\"page_item page-item-32158\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/evaluation-annuelle-2024\/\">\u00c9valuation annuelle 2024<\/a><\/li>\n<li class=\"page_item page-item-21989\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/adenocarcinome-oesophagien-resume-a-lintention-des-cliniciens\/\">Ad\u00e9nocarcinome \u0153sophagien\u2014R\u00e9sum\u00e9 \u00e0 l\u2019intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-20959\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/dysfonctionnement-thyroidien-faq-pour-cliniciens\/\">Dysfonctionnement thyro\u00efdien &#8211; FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-20631\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/dysfonctionnement-thyroidien-resume-a-lintention-des-cliniciens\/\">Dysfonctionnement thyro\u00efdien\u2014R\u00e9sum\u00e9 \u00e0 l\u2019intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-14452\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-sein\/\">Cancer du sein<\/a><\/li>\n<li class=\"page_item page-item-11633\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-colorectal-presentation-de-la-ligne-directrice\/\">Cancer Colorectal\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-11649\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/depression-presentation-de-la-ligne-directrice\/\">D\u00e9pression\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-11613\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/retard-de-developpement-presentation-de-la-ligne-directrice\/\">Retard de d\u00e9veloppement\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-10337\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/general-information\/\">Grand public<\/a><\/li>\n<li class=\"page_item page-item-11317\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/autres-lignes-directrices-1979-2006\/\">Autres lignes directrices (1979\u20132006)<\/a><\/li>\n<li class=\"page_item page-item-11320\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/autres-documents-1979-2006\/\">Autres documents (1979\u20132006)<\/a><\/li>\n<li class=\"page_item page-item-11284\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/appercu-de-levaluation-critique\/\">Apper\u00e7u de l&rsquo;\u00e9valuation critique<\/a><\/li>\n<li class=\"page_item page-item-10401\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-de-la-prostate-faq-pour-cliniciens\/\">Cancer de la prostate\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-11805\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignes-directrices-publiees-public\/\">Lignes directrices publi\u00e9es (Public)<\/a><\/li>\n<li class=\"page_item page-item-11315\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/la-brique-rouge-guide-canadien-de-medecine-clinique-preventive-1994\/\">\u00ab La Brique rouge \u00bb: Guide canadien de m\u00e9decine clinique pr\u00e9ventive (1994)<\/a><\/li>\n<li class=\"page_item page-item-12662\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tabagisme-chez-les-enfants-et-les-adolescents-presentation-de-la-ligne-directrice\/\">Tabagisme chez les enfants et les adolescents\u2014 Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-11806\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/outils-public\/\">Outils (Public)<\/a><\/li>\n<li class=\"page_item page-item-10678\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/diabete-de-type-2-resume-a-lintention-des-cliniciens\/\">Diab\u00e8te de type 2\u2014R\u00e9sum\u00e9 \u00e0 l&rsquo;intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-11627\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-sein-presentation-de-la-ligne-directrice\/\">Cancer du sein\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-10216\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-colorectal-ressources\/\">Cancer Colorectal\u2014Ressources<\/a><\/li>\n<li class=\"page_item page-item-10173\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-col-de-luterus-resume-a-lintention-des-cliniciens\/\">Cancer du col de l&rsquo;ut\u00e9rus\u2014R\u00e9sum\u00e9 \u00e0 l&rsquo;intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10176\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cervical-cancer-guideline-presentation\/\">Cancer du col de l\u2019ut\u00e9rus\u2014 Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-10188\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/deficience-cognitive-resume-a-lintention-des-cliniciens\/\">D\u00e9ficience cognitive\u2014R\u00e9sum\u00e9 \u00e0 l&rsquo;intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-32771\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/depression-chez-ladulte-mise-a-jour-resume-a-lintention-des-cliniciens\/\">D\u00e9pression chez l\u2019adulte (mise \u00e0 jour)\u2014R\u00e9sum\u00e9 \u00e0 l&rsquo;intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-32487\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tabagisme-chez-ladulte-resume-a-lintention-des-cliniciens\/\">Tabagisme chez l\u2019adulte\u2014R\u00e9sum\u00e9 \u00e0 l&rsquo;intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10192\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cognitive-impairment-guideline-presentation\/\">D\u00e9ficience cognitive\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-13506\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/anevrisme-aortique-abdominal-resume-a-lintention-des-cliniciens\/\">An\u00e9vrisme aortique abdominal\u2014R\u00e9sum\u00e9 \u00e0 l\u2019intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-23670\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/chlamydia-et-gonorrhee-resume-a-lintention-des-cliniciens\/\">Chlamydia et gonorrh\u00e9e\u2014R\u00e9sum\u00e9 \u00e0 l\u2019intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-25384\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/depression-pendant-la-grossesse-et-la-periode-postnatale-resume-a-lintention-des-cliniciens\/\">D\u00e9pression pendant la grossesse et la p\u00e9riode postnatale\u2014R\u00e9sum\u00e9 \u00e0 l\u2019intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-26879\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/fracture-de-fragilisation-resume-a-lintention-des-cliniciens\/\">Fracture De Fragilisation\u2014R\u00e9sum\u00e9 \u00e0 l\u2019intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-17043\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/bacteriurie-asymptomatique-resume-a-lintention-des-cliniciens\/\">Bact\u00e9riurie asymptomatique au cours de la grossesse\u2014R\u00e9sum\u00e9 \u00e0 l\u2019intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-18902\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-sein-mis-a-jour-resume-a-lintention-des-cliniciens\/\">Cancer du sein (mis \u00e0 jour)\u2014R\u00e9sum\u00e9 \u00e0 l\u2019intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10212\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-colorectal-resume-a-lintention-des-cliniciens\/\">Cancer colorectal\u2014R\u00e9sum\u00e9 \u00e0 l&rsquo;intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-12738\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/hepatite-c-resume-a-lintention-des-cliniciens\/\">H\u00e9patite C\u2014R\u00e9sum\u00e9 \u00e0 l\u2019intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-16963\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/troubles-de-la-vision-resume-a-lintention-des-cliniciens\/\">Troubles de la vision\u2014R\u00e9sum\u00e9 \u00e0 l\u2019intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10223\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/depression-resume-a-lintention-des-cliniciens\/\">D\u00e9pression\u2014R\u00e9sum\u00e9 \u00e0 l&rsquo;intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10233\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/retard-de-developpement-resume-a-lintention-des-cliniciens\/\">Retard de d\u00e9veloppement\u2014R\u00e9sum\u00e9 \u00e0 l&rsquo;intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-12516\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tabagisme-chez-les-enfants-et-les-adolescents-resume-a-lintention-des-cliniciens\/\">Tabagisme chez les enfants et les adolescents\u2014R\u00e9sum\u00e9 \u00e0 l\u2019intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10268\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/hypertension-clinician-summary\/\">Hypertension art\u00e9rielle\u2014R\u00e9sum\u00e9 \u00e0 l&rsquo;intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10287\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-poumon-resume-a-lintention-des-cliniciens\/\">Cancer du poumon\u2014R\u00e9sum\u00e9 \u00e0 l&rsquo;intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-14905\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/hypertension-arterielle-presentation-de-la-ligne-directrice\/\">Hypertension art\u00e9rielle\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-15143\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-poumon-presentation-de-la-ligne-directrice\/\">Cancer du poumon\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-10312\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/obesity-in-adults-guideline-presentation\/\">Ob\u00e9sit\u00e9 adulte\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-10391\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/obesite-juvenile-resume-pour-cliniciens\/\">Ob\u00e9sit\u00e9 Juv\u00e9nile\u2014R\u00e9sum\u00e9 pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-22198\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/adenocarcinome-oesophagien-presentation-de-la-ligne-directrice\/\">Ad\u00e9nocarcinome \u0153sophagien\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-17165\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/bacteriurie-asymptomatique-presentation-de-la-ligne-directrice\/\">Bact\u00e9riurie asymptomatique au cours de la grossesse\u2014Presentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-22462\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/dysfonctionnement-thyroidien-presentation-de-la-ligne-directrice\/\">Dysfonctionnement thyro\u00efdien\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-18948\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-sein-mis-a-jour-presentation-de-la-ligne-directrice\/\">Cancer du sein (mis \u00e0 jour)\u2014\ufeffPr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-23693\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/chlamydia-et-gonorrhee-presentation-de-la-ligne-directrice\/\">Chlamydia et gonorrh\u00e9e\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-32965\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/depression-chez-ladulte-mise-a-jour-presentation-du-guide-de-pratique-clinique\/\">D\u00e9pression chez l\u2019adulte (mise \u00e0 jour)\u2014Pr\u00e9sentation du guide de pratique Clinique<\/a><\/li>\n<li class=\"page_item page-item-25366\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/depression-pendant-la-grossesse-et-la-periode-postnatale-presentation-de-la-ligne-directrice\/\">D\u00e9pression pendant la grossesse et la p\u00e9riode postnatale\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-27517\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/fracture-de-fragilisation-presentation-de-la-ligne-directrice\/\">Fracture De Fragilisation\u2014Pr\u00e9sentation De La Ligne Directrice<\/a><\/li>\n<li class=\"page_item page-item-32869\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tabagisme-chez-ladulte-presentation-du-guide-de-pratique-clinique\/\">Tabagisme chez l\u2019adulte\u2014Pr\u00e9sentation du guide de pratique Clinique<\/a><\/li>\n<li class=\"page_item page-item-14756\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/hepatite-c-presentation-de-la-ligne-directrice\/\">H\u00e9patite C\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-17032\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/troubles-de-la-vision-presentation-de-la-ligne-directrice\/\">Troubles de la vision\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-10394\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/obesite-juvenile-presentation-de-la-ligne-directrice\/\">Ob\u00e9sit\u00e9 juv\u00e9nile \u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-10309\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/obesite-adulte-resume-pour-cliniciens\/\">Ob\u00e9sit\u00e9 adulte\u2014R\u00e9sum\u00e9 pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10418\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-de-la-prostate-resume-a-lintention-des-cliniciens\/\">Cancer de la prostate\u2014R\u00e9sum\u00e9 \u00e0 l&rsquo;intention des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10421\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-de-la-prostate-presentation-de-la-ligne-directrice\/\">Cancer de la prostate\u2014Pr\u00e9sentation de la ligne directrice<\/a><\/li>\n<li class=\"page_item page-item-10347 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/get-involved\/\">Apportez votre contribution<\/a>\n<ul class='children'>\n\t<li class=\"page_item page-item-20464\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/get-involved\/amanda-tzenov\/\">Amanda Tzenov<\/a><\/li>\n\t<li class=\"page_item page-item-26499\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/get-involved\/dr-shez-kassam\/\">Dr Shez Kassam<\/a><\/li>\n\t<li class=\"page_item page-item-28884\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/get-involved\/dr-olivia-tseng\/\">Dr. Olivia Tseng<\/a><\/li>\n\t<li class=\"page_item page-item-22990\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/get-involved\/keith-todd\/\">Keith Todd<\/a><\/li>\n\t<li class=\"page_item page-item-22984\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/get-involved\/richard-henry\/\">Richard Henry<\/a><\/li>\n\t<li class=\"page_item page-item-24600\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/get-involved\/clinical-prevention-leaders-new\/\">R\u00e9seau de leaders en pr\u00e9vention clinique New<\/a><\/li>\n<\/ul>\n<\/li>\n<li class=\"page_item page-item-9934\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-sein-recommandations-du-depistage-par-mammographie-pour-cliniciens\/\">Cancer du sein\u2014Recommandations du d\u00e9pistage par mammographie pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-9926\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-sein-recommandations-ecsaes-pour-cliniciens\/\">Cancer du sein\u2014Recommandations ECS\/AES pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10334 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/methodologie\/\">[Archiv\u00e9]\u00a0M\u00e9thodologie<\/a>\n<ul class='children'>\n\t<li class=\"page_item page-item-11217\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/methodologie\/grade\/\">GRADE<\/a><\/li>\n\t<li class=\"page_item page-item-13893\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/methodologie\/manuel-des-procedures\/\">Manuel des proc\u00e9dures<\/a><\/li>\n\t<li class=\"page_item page-item-28420\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/methodologie\/updating-reaffirmation-and-sunsetting-clinical-practice-guidelines-methods-from-the-canadian-task-force-on-preventive-health-care\/\">Mise \u00e0 jour, r\u00e9affirmation et caducit\u00e9 des\u00a0lignes directrices de pratique clinique\u00a0<\/a><\/li>\n\t<li class=\"page_item page-item-11577\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/methodologie\/protocole-relatif-aux-preferences-des-patients\/\">Protocole de participation du patient<\/a><\/li>\n<\/ul>\n<\/li>\n<li class=\"page_item page-item-29801\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/cancer-du-sein-mise-a-jour-recommandations-provisoires\/\">Cancer du Sein (mise \u00e0 jour) \u2013 Recommandations provisoires<\/a><\/li>\n<li class=\"page_item page-item-10239\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/\">Accueil<\/a><\/li>\n<li class=\"page_item page-item-17909\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/evaluation-annuelle-2017\/\">\u00c9valuation annuelle 2017<\/a><\/li>\n<li class=\"page_item page-item-16284\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/stagiaires-2018\/\">Stagiaires 2018<\/a><\/li>\n<li class=\"page_item page-item-9768 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/a-propos-du-gecssp\/\">\u00c0 propos du GECSSP<\/a>\n<ul class='children'>\n\t<li class=\"page_item page-item-9772\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/a-propos-du-gecssp\/histoire\/\">Histoire<\/a><\/li>\n\t<li class=\"page_item page-item-22942\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/a-propos-du-gecssp\/conflits-dinterets\/\">[Archiv\u00e9] Conflits D\u2019int\u00e9r\u00eats<\/a><\/li>\n<\/ul>\n<\/li>\n<li class=\"page_item page-item-11877\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/contact\/\">Nous joindre<\/a><\/li>\n<li class=\"page_item page-item-9818 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/\">Lignes Directrices<\/a>\n<ul class='children'>\n\t<li class=\"page_item page-item-15217\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/visites-periodiques-en-sante-preventive\/\">Visites p\u00e9riodiques en sant\u00e9 pr\u00e9ventive<\/a><\/li>\n\t<li class=\"page_item page-item-9821 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/\">Lignes directrices publi\u00e9es<\/a>\n\t<ul class='children'>\n\t\t<li class=\"page_item page-item-21258\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/adenocarcinome-oesophagien\/\">Ad\u00e9nocarcinome \u0153sophagien (2020)<\/a><\/li>\n\t\t<li class=\"page_item page-item-23647\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/chlamydia-et-gonorrhee\/\">Chlamydia et gonorrh\u00e9e (2021)<\/a><\/li>\n\t\t<li class=\"page_item page-item-25159\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/depression-pendant-la-grossesse-et-la-periode-postnatale\/\">D\u00e9pression pendant la grossesse et la p\u00e9riode postnatale (2022)<\/a><\/li>\n\t\t<li class=\"page_item page-item-20554\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/dysfonctionnement-thyroidien\/\">Dysfonctionnement thyro\u00efdien (2019)<\/a><\/li>\n\t\t<li class=\"page_item page-item-26812\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/fracture-de-fragilisation\/\">Fracture De Fragilisation (2023)<\/a><\/li>\n\t\t<li class=\"page_item page-item-17040\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/bacteriurie-asymptomatique\/\">Bact\u00e9riurie asymptomatique au cours de la grossesse (2018)<\/a><\/li>\n\t\t<li class=\"page_item page-item-20189\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/anevrisme-aortique-abdominal\/\">An\u00e9vrisme de l&rsquo;aorte abdominale (2017)<\/a><\/li>\n\t\t<li class=\"page_item page-item-29196\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/cancer-du-sein-mise-a-jour-2024\/\">[Archiv\u00e9] Conflits D\u2019int\u00e9r\u00eatsCancer du Sein (mise \u00e0 jour) -Recommandations provisoires (2024)<\/a><\/li>\n\t\t<li class=\"page_item page-item-10759\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/cancer-du-col-de-luterus\/\">Cancer du col de l&rsquo;ut\u00e9rus (2013)<\/a><\/li>\n\t\t<li class=\"page_item page-item-10763\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/deficience-cognitive\/\">D\u00e9ficience cognitive (2024)<\/a><\/li>\n\t\t<li class=\"page_item page-item-10767\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/cancer-colorectal\/\">Cancer colorectal (2016)<\/a><\/li>\n\t\t<li class=\"page_item page-item-32741\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/depression-chez-ladulte-mise-a-jour\/\">D\u00e9pression chez l\u2019adulte (mise \u00e0 jour) (2025)<\/a><\/li>\n\t\t<li class=\"page_item page-item-10779\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/retard-de-developpement\/\">Retard de d\u00e9veloppement (2016)<\/a><\/li>\n\t\t<li class=\"page_item page-item-10809\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/diabete-de-type-2\/\">Diab\u00e8te de type 2 (2012)<\/a><\/li>\n\t\t<li class=\"page_item page-item-12723\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/hepatite-c\/\">H\u00e9patite C (2017)<\/a><\/li>\n\t\t<li class=\"page_item page-item-10785\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/hypertension-arterielle\/\">Hypertension art\u00e9rielle (2012)<\/a><\/li>\n\t\t<li class=\"page_item page-item-16956\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/troubles-de-la-vision\/\">Troubles de la vision (2018)<\/a><\/li>\n\t\t<li class=\"page_item page-item-10789\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/cancer-du-poumon\/\">Cancer du poumon (2016)<\/a><\/li>\n\t\t<li class=\"page_item page-item-10802\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/pelvic-exam\/\">Examen pelvien (2016)<\/a><\/li>\n\t\t<li class=\"page_item page-item-10805\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/cancer-de-la-prostate\/\">Cancer de la prostate (2014)<\/a><\/li>\n\t\t<li class=\"page_item page-item-11253\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/lignes-directrices-publiees-annee\/\">Lignes directrices publi\u00e9es\u2014Ann\u00e9e<\/a><\/li>\n\t\t<li class=\"page_item page-item-32200\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/tabagisme-chez-ladulte\/\">Tabagisme chez l\u2019adulte (2025)<\/a><\/li>\n\t\t<li class=\"page_item page-item-12468\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/tabagisme-chez-les-enfants-et-les-adolescents\/\">Tabagisme chez les enfants et les adolescents (2017)<\/a><\/li>\n\t\t<li class=\"page_item page-item-10829\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/lignes-directrices-publiees\/lignes-directrices-publiees-sexe-et-tranche-dage\/\">Lignes directrices publi\u00e9es &#8211; Sexe et tranche d\u2019\u00e2ge<\/a><\/li>\n\t<\/ul>\n<\/li>\n\t<li class=\"page_item page-item-27708\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/autres-publications\/\">Autres publications<\/a><\/li>\n\t<li class=\"page_item page-item-19734\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/revues-systematiques-et-protocoles\/\">Revues Syst\u00e9matiques et Protocoles<\/a><\/li>\n\t<li class=\"page_item page-item-31009\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/scores-d-evaluation-ecri\/\">Scores d&rsquo;\u00e9valuation (ECRI)<\/a><\/li>\n\t<li class=\"page_item page-item-16202\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/serie-prevention-en-pratique\/\">S\u00e9rie Pr\u00e9vention en pratique<\/a><\/li>\n\t<li class=\"page_item page-item-10751 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/appraised-guidelines\/\">Lignes directrices \u00e9valu\u00e9es<\/a>\n\t<ul class='children'>\n\t\t<li class=\"page_item page-item-11310\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/appraised-guidelines\/cancer-de-lovaire\/\">Cancer de l&rsquo;ovaire<\/a><\/li>\n\t\t<li class=\"page_item page-item-11286\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/appraised-guidelines\/fibrillation-auriculaire\/\">Fibrillation auriculaire<\/a><\/li>\n\t\t<li class=\"page_item page-item-11302\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/appraised-guidelines\/melanome\/\">M\u00e9lanome<\/a><\/li>\n\t\t<li class=\"page_item page-item-11306\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/appraised-guidelines\/osteoporose\/\">Ost\u00e9oporose<\/a><\/li>\n\t\t<li class=\"page_item page-item-11297\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/appraised-guidelines\/vih\/\">VIH<\/a><\/li>\n\t\t<li class=\"page_item page-item-11291\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/lignesdirectrives\/appraised-guidelines\/domestic-violence-familiale\/\">Violence familiale<\/a><\/li>\n\t<\/ul>\n<\/li>\n<\/ul>\n<\/li>\n<li class=\"page_item page-item-14286\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/anevrisme-de-laorte-abdominale-algorithme-clinique\/\">An\u00e9vrisme de l\u2019aorte abdominale\u2014Tableau de recommandations<\/a><\/li>\n<li class=\"page_item page-item-10201\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-colorectal-tableau-de-recommandations\/\">Cancer Colorectal\u2014Tableau de recommandations<\/a><\/li>\n<li class=\"page_item page-item-10413\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-de-la-prostate-resume-graphique\/\">Cancer de la prostate\u2014R\u00e9sum\u00e9 graphique<\/a><\/li>\n<li class=\"page_item page-item-30615\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-sein-mise-a-jour-outils-d-aide-a-la-decision-personnes-agees-de-40-a-49-ans\/\">Cancer du sein (mise \u00e0 jour)\u2014Recommandations provisoires\u2014Outils d&rsquo;aide \u00e0 la d\u00e9cision \u2013 Personnes \u00e2g\u00e9es de 40 \u00e0 49\u00a0ans<\/a><\/li>\n<li class=\"page_item page-item-30616\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-sein-mise-a-jour-outils-d-aide-a-la-decision-personnes-agees-de-50-a-59-ans\/\">Cancer du sein (mise \u00e0 jour)\u2014Recommandations provisoires\u2014Outils d&rsquo;aide \u00e0 la d\u00e9cision \u2013 Personnes \u00e2g\u00e9es de 50 \u00e0 59\u00a0ans<\/a><\/li>\n<li class=\"page_item page-item-30617\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-sein-mise-a-jour-outils-d-aide-a-la-decision-personnes-agees-de-60-a-69-ans\/\">Cancer du sein (mise \u00e0 jour)\u2014Recommandations provisoires\u2014Outils d&rsquo;aide \u00e0 la d\u00e9cision \u2013 Personnes \u00e2g\u00e9es de 60 \u00e0 69\u00a0ans\u00a0<\/a><\/li>\n<li class=\"page_item page-item-30618\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-sein-mise-a-jour-outils-d-aide-a-la-decision-personnes-agees-de-70-a-79-ans\/\">Cancer du sein (mise \u00e0 jour)\u2014Recommandations provisoires\u2014Outils d&rsquo;aide \u00e0 la d\u00e9cision \u2013 Personnes \u00e2g\u00e9es de 70 \u00e0 79\u00a0ans\u00a0<\/a><\/li>\n<li class=\"page_item page-item-29522\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-sein-mise-a-jour-recommandations-provisoires-resume-visuel-graphique\/\">Cancer du sein (mise \u00e0 jour)\u2014Recommandations provisoires\u2014Resume visuel graphique<\/a><\/li>\n<li class=\"page_item page-item-23449\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/chlamydia-et-gonorrhee\/\">Chlamydia et gonorrh\u00e9e<\/a><\/li>\n<li class=\"page_item page-item-25393\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/depression-pendant-la-grossesse-et-la-periode-postnatale\/\">D\u00e9pression pendant la grossesse et la p\u00e9riode postnatale<\/a><\/li>\n<li class=\"page_item page-item-26814\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/fracture-de-fragilisation\/\">Fracture De Fragilisation<\/a><\/li>\n<li class=\"page_item page-item-27125\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/fracture-de-fragilisation-infographie-a-lintention-des-cliniciens\/\">Fracture de fragilisation\u2014Infographie des cliniciens<\/a><\/li>\n<li class=\"page_item page-item-27266\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/fragility-fractures-decision-aid\/\">Outils d\u2019aide pour une prise de d\u00e9cision partag\u00e9e<\/a><\/li>\n<li class=\"page_item page-item-10386\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/prevention-et-gestion-de-lobesite-juvenile-tableau-de-recommandations\/\">Pr\u00e9vention et gestion de l&rsquo;ob\u00e9sit\u00e9 juv\u00e9nile\u2014Tableau de recommandations<\/a><\/li>\n<li class=\"page_item page-item-20103\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/troubles-de-la-vision-2\/\">Troubles de la vision<\/a><\/li>\n<li class=\"page_item page-item-11062 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-col-de-luterus\/\">Cancer du col de l&rsquo;ut\u00e9rus<\/a><\/li>\n<li class=\"page_item page-item-20573\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/dysfonctionnement-thyroidien\/\">Dysfonctionnement thyro\u00efdien<\/a><\/li>\n<li class=\"page_item page-item-21380\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/adenocarcinome-oesophagien-faq-pour-cliniciens\/\">Ad\u00e9nocarcinome \u0153sophagien \u2013 FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-21388\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/adenocarcinome-oesophagien-faq-pour-patients\/\">Ad\u00e9nocarcinome \u0153sophagien \u2013 FAQ pour patients<\/a><\/li>\n<li class=\"page_item page-item-14278\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/anevrisme-de-laorte-abdominale-de-la-prostate-avantages-et-inconvenients\/\">An\u00e9vrisme de l\u2019aorte abdominale\u2014Outil de d\u00e9pistage aupr\u00e8s de 1000 personnes<\/a><\/li>\n<li class=\"page_item page-item-10409\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-de-la-prostate-avantages-et-inconvenients\/\">Cancer de la prostate\u2014Outil de d\u00e9pistage aupr\u00e8s de 1000 personnes<\/a><\/li>\n<li class=\"page_item page-item-23453\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/chlamydia-and-gonorrhea-clinician-faq\/\">Chlamydia et gonorrh\u00e9e\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-23447\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/chlamydia-and-gonorrhea-patient-faq\/\">Chlamydia et gonorrh\u00e9e\u2014FAQ pour patients<\/a><\/li>\n<li class=\"page_item page-item-23739\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/chlamydia-and-gonorrhea-infographic\/\">Chlamydia et gonorrh\u00e9e\u2014Re\u0301sume\u0301 visuel graphique<\/a><\/li>\n<li class=\"page_item page-item-32752\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/depression-chez-ladulte-mise-a-jour-infographie-pour-les-cliniciens\/\">D\u00e9pression chez l\u2019adulte (mise \u00e0 jour)\u2014Infographie pour les cliniciens<\/a><\/li>\n<li class=\"page_item page-item-32758\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/depression-chez-ladulte-mise-a-jour-infographie-pour-les-patients\/\">D\u00e9pression chez l\u2019adulte (mise \u00e0 jour)\u2014Infographie pour les patients<\/a><\/li>\n<li class=\"page_item page-item-25319\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/depression-pendant-la-grossesse-et-la-periode-postnatale-faq-pour-cliniciens\/\">D\u00e9pression pendant la grossesse et la p\u00e9riode postnatale\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-25283\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/depression-pendant-la-grossesse-et-la-periode-postnatale-faq-pour-patients\/\">D\u00e9pression pendant la grossesse et la p\u00e9riode postnatale\u2014FAQ pour patients<\/a><\/li>\n<li class=\"page_item page-item-25323\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/depression-pendant-la-grossesse-et-la-periode-postnatale-resume-visuel-graphique\/\">D\u00e9pression pendant la grossesse et la p\u00e9riode postnatale\u2014Re\u0301sume\u0301 visuel graphique<\/a><\/li>\n<li class=\"page_item page-item-32228\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/tabagisme-chez-ladulte-outil-de-discussion-avec-le-patient\/\">Tabagisme chez l\u2019adulte\u2014Outil de discussion avec le patient<\/a><\/li>\n<li class=\"page_item page-item-32215\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/tabagisme-chez-ladulte-resume-graphique\/\">Tabagisme chez l\u2019adulte\u2014R\u00e9sum\u00e9 Graphique<\/a><\/li>\n<li class=\"page_item page-item-32764\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/depression-chez-ladulte-mise-a-jour\/\">D\u00e9pression chez l\u2019adulte (mise \u00e0 jour)<\/a><\/li>\n<li class=\"page_item page-item-32216\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/tabagisme-chez-ladulte\/\">Tabagisme chez l\u2019adulte<\/a><\/li>\n<li class=\"page_item page-item-12560 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/tabagisme-chez-les-enfants-et-les-adolescents\/\">Tabagisme chez les enfants et les adolescents<\/a><\/li>\n<li class=\"page_item page-item-11085\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-de-la-prostate\/\">Cancer de la prostate<\/a><\/li>\n<li class=\"page_item page-item-10208\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-colorectal-faq-pour-patientes\/\">Cancer colorectal\u2014FAQ pour patients<\/a><\/li>\n<li class=\"page_item page-item-21752\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/depister-avec-soin\/\">D\u00e9pister avec soin<\/a><\/li>\n<li class=\"page_item page-item-12764\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/hepatite-c-faq-pour-cliniciens\/\">H\u00e9patite C\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-24946\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/information-sur-le-depistage\/\">Information sur le d\u00e9pistage<\/a><\/li>\n<li class=\"page_item page-item-16984\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/troubles-de-la-vision-faq-pour-cliniciens\/\">Troubles de la vision\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10405\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-de-la-prostate-faq-pour-patients\/\">Cancer de la prostate\u2014FAQ pour patients<\/a><\/li>\n<li class=\"page_item page-item-11088 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/diabete-de-type-2\/\">Diab\u00e8te de type 2<\/a><\/li>\n<li class=\"page_item page-item-11073 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/hypertension-arterielle\/\">Hypertension art\u00e9rielle<\/a><\/li>\n<li class=\"page_item page-item-21918\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/adenocarcinome-oesophagien\/\">Ad\u00e9nocarcinome \u0153sophagien<\/a><\/li>\n<li class=\"page_item page-item-14659\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/anevrisme-de-laorte-abdominale-2\/\">An\u00e9vrisme de l\u2019aorte abdominale<\/a><\/li>\n<li class=\"page_item page-item-21754\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/depister-avec-soin-2\/\">D\u00e9pister avec soin<\/a><\/li>\n<li class=\"page_item page-item-12732\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/hepatite-c\/\">H\u00e9patite C<\/a><\/li>\n<li class=\"page_item page-item-11071 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/retard-de-developpement\/\">Retard de d\u00e9veloppement<\/a><\/li>\n<li class=\"page_item page-item-16953 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/bacteriurie-asymptomatique\/\">Bact\u00e9riurie asymptomatique au cours de la grossesse<\/a><\/li>\n<li class=\"page_item page-item-11075 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-poumon\/\">Cancer du poumon<\/a><\/li>\n<li class=\"page_item page-item-11064 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/deficience-cognitive\/\">D\u00e9ficience cognitive<\/a><\/li>\n<li class=\"page_item page-item-11069 page_item_has_children\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/depression\/\">D\u00e9pression<\/a><\/li>\n<li class=\"page_item page-item-29723\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-sein-mise-a-jour-recommandations-provisoires-2024\/\">Cancer du sein (mise \u00e0 jour) \u2013 Recommandations provisoires (2024)<\/a><\/li>\n<li class=\"page_item page-item-11067\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-colorectal\/\">Cancer colorectal<\/a><\/li>\n<li class=\"page_item page-item-10039\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-col-de-luterus\/cancer-du-col-de-luterus-faq-pour-cliniciens\/\">Cancer du col de l&rsquo;ut\u00e9rus\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10169\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-col-de-luterus\/cervical-cancer-patient-faq\/\">Cancer du col de l&rsquo;ut\u00e9rus\u2014FAQ pour patients<\/a><\/li>\n<li class=\"page_item page-item-10036\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-col-de-luterus\/algorithme-pour-cliniciens\/\">Cancer du col de l\u2019ut\u00e9rus\u2014Algorithme pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10166\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-col-de-luterus\/cancer-du-col-de-luterus-algorithme-pour-patientes\/\">Cancer du col de l&rsquo;ut\u00e9rus\u2014Algorithme pour patients<\/a><\/li>\n<li class=\"page_item page-item-10273\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-poumon\/cancer-du-poumon-faq-pour-cliniciens\/\">Cancer du poumon\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10279\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-poumon\/cancer-du-poumon-avantages-et-inconvenients\/\">Cancer du poumon\u2014Outil de d\u00e9pistage aupr\u00e8s de 1000 personnes<\/a><\/li>\n<li class=\"page_item page-item-16296\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/media__trashed\/press-releases\/\">Communiqu\u00e9 de presse<\/a><\/li>\n<li class=\"page_item page-item-16300\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/media__trashed\/media-links\/\">Lien m\u00e9dia<\/a><\/li>\n<li class=\"page_item page-item-10184\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/deficience-cognitive\/deficience-cognitive-faq-pour-cliniciens\/\">D\u00e9ficience cognitive\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10219\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/depression\/depression-algorithme-et-faq-pour-cliniciens\/\">D\u00e9pression\u2014Algorithme et FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10584\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/diabete-de-type-2\/diabete-de-type-2-faq-pour-cliniciens\/\">Diab\u00e8te de type 2\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10594\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/diabete-de-type-2\/diabete-de-type-2-findrisc-pour-cliniciens\/\">Diab\u00e8te de type 2\u2014FINDRISC pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10623\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/diabete-de-type-2\/diabete-de-type-2-findrisc-pour-patients\/\">Diab\u00e8te de type 2\u2014FINDRISC pour patients<\/a><\/li>\n<li class=\"page_item page-item-10611\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/diabete-de-type-2\/diabete-de-type-2-faq-pour-patients\/\">Diab\u00e8te de type 2\u2014FAQ pour patients<\/a><\/li>\n<li class=\"page_item page-item-10647\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/diabete-de-type-2\/diabete-de-type-2-canrisk\/\">Diab\u00e8te de type 2\u2014CANRISK<\/a><\/li>\n<li class=\"page_item page-item-10261\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/hypertension-arterielle\/hypertension-clinician-algorithm\/\">Hypertension art\u00e9rielle\u2014Algorithme pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10264\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/hypertension-arterielle\/hypertension-arterielle-comment-mesurer-la-pression-arterielle\/\">Hypertension art\u00e9rielle\u2014Comment mesurer la pression art\u00e9rielle<\/a><\/li>\n<li class=\"page_item page-item-10302\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/obesite-adulte__trashed\/obesite-adulte-algorithme-pour-cliniciens\/\">Ob\u00e9sit\u00e9 adulte\u2014Algorithme pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-10298\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/obesite-adulte__trashed\/obesite-adulte-faq-pour-cliniciens\/\">Ob\u00e9sit\u00e9 Adulte\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-23076\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/a-propos-du-gecssp\/proces-verbaux__trashed\/public-record-of-meeting-26-october-2020\/\">Public record of meeting, 26 October 2020<\/a><\/li>\n<li class=\"page_item page-item-10229\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/retard-de-developpement\/retard-de-developpement-faq-pour-cliniciens\/\">Retard de d\u00e9veloppement\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-12456\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/tabagisme-chez-les-enfants-et-les-adolescents\/tabagisme-chez-les-enfants-et-les-adolescents-2\/\">Tabagisme chez les enfants et les adolescents\u2014FAQ pour cliniciens<\/a><\/li>\n<li class=\"page_item page-item-9841\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-sein__trashed\/cancer-du-sein-faq-pour-patientes\/\">Cancer du sein (2011)\u2014FAQ pour patients<\/a><\/li>\n<li class=\"page_item page-item-19384\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-sein-mise-a-jour__trashed\/outil-de-depistage-aupres-de-1000-personnes\/\">Cancer du sein (mise \u00e0 jour) (2018)\u00a0\u2014Outil de d\u00e9pistage aupr\u00e8s de 1000 personnes<\/a><\/li>\n<li class=\"page_item page-item-22349\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-sein-mise-a-jour__trashed\/outil-daide-a-la-prise-de-decision-partagee-personnes-agees-de-40-a-49-ans\/\">Cancer du sein (mise \u00e0 jour) (2018)\u2014Outil d\u2019aide a\u0300 la prise de de\u0301cision partag\u00e9e, personnes \u00e2g\u00e9es de 40 a\u0300 49 ans<\/a><\/li>\n<li class=\"page_item page-item-28037\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/cancer-du-sein-mise-a-jour__trashed\/cancer-du-sein-mise-a-jour-faqs\/\">Cancer du sein (mise \u00e0 jour) (2023) \u2014FAQs<\/a><\/li>\n<li class=\"page_item page-item-16909\"><a href=\"https:\/\/canadiantaskforce.ca\/fr\/tools-resources__trashed\/bacteriurie-asymptomatique\/bacteriurie-asymptomatique-faq-pour-cliniciens\/\">Bact\u00e9riurie asymptomatique au cours de la grossesse\u2014FAQ pour cliniciens<\/a><\/li>\n<\/ul><\/span>\n<div class=\"dt-sc-tabs-vertical2-frame-content\"><div class='pdfdownload'><h5>Version PDF<\/h5><hr><div class='pdfdownload-text'><a href=\"https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2016\/09\/ctfphccolorectal-cancerrecommendation-tablefrenchfinal.pdf\" target=\"_blank\" rel=\"noopener\">PDF Couleur<\/a>\n<a href=\"https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2016\/09\/ctfphccolorectal-cancerrecommendation-tablefrenchfinalbw.pdf\" target=\"_blank\" rel=\"noopener\">PDF Noir et Blanc<\/a><\/div><\/div>\n<div class='back'><h4><span class='fa fa-angle-left'><\/span>&nbsp;<a href='\/lignesdirectrives\/lignes-directrices-publiees\/cancer-colorectal\/?lang=fr'>Retour<\/a><\/h4><\/div>\n<section id=\"who-do-these-recommendations-apply-to\" class=\"ctfphc-section\">\n<h3><\/h3>\n<h3>\u00c0 QUI CES RECOMMANDATIONS S\u2019APPLIQUENT-ELLES ?<\/h3>\n<p>Ces recommandations s\u2019appliquent aux <strong>adultes asymptomatiques \u00e2g\u00e9s de 50 ans et plus ne pr\u00e9sentant pas de risque \u00e9lev\u00e9 de cancer colorectal (CCR)<\/strong>. Les adultes pr\u00e9sentent un risque \u00e9lev\u00e9 s\u2019ils r\u00e9pondent \u00e0 au moins un des crit\u00e8res suivants :<\/p>\n<ul>\n<li>CCR ou polypes ad\u00e9nomateux (p. ex., tubulaire ou villeux) ant\u00e9rieurs<\/li>\n<li>maladie intestinale inflammatoire (p. ex., colite ulc\u00e9reuse ou maladie de Crohn)<\/li>\n<li>signes ou sympt\u00f4mes de CCR (p. ex., sang dans les selles) ;<\/li>\n<li>ant\u00e9c\u00e9dents de CCR chez un ou plusieurs parents au premier degr\u00e9<\/li>\n<li>syndromes h\u00e9r\u00e9ditaires pr\u00e9disposant au CCR (p. ex., polypose ad\u00e9nomateuse familiale ou syndrome de Lynch)<\/li>\n<\/ul>\n<\/section>\n<div class=\"ctfphc-section ctfphc-section-notitle\">\n<p>Cet outil fournit des orientations aux professionnel en soins primaires sur les diff\u00e9rents tests de d\u00e9pistage, les intervalles de d\u00e9pistage et les \u00e2ges recommand\u00e9s pour d\u00e9marrer et arr\u00eater le d\u00e9pistage.<a href=\"https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2016\/09\/colorectal-cancerclinician-recommendation-tablefrench.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"aligncenter size-full wp-image-10204\" src=\"https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2016\/09\/colorectal-cancerclinician-recommendation-tablefrench.jpg\" alt=\"colorectal-cancerclinician-recommendation-tablefrench\" width=\"910\" height=\"345\" srcset=\"https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2016\/09\/colorectal-cancerclinician-recommendation-tablefrench.jpg 910w, https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2016\/09\/colorectal-cancerclinician-recommendation-tablefrench-600x227.jpg 600w, https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2016\/09\/colorectal-cancerclinician-recommendation-tablefrench-300x114.jpg 300w, https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2016\/09\/colorectal-cancerclinician-recommendation-tablefrench-768x291.jpg 768w, https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2016\/09\/colorectal-cancerclinician-recommendation-tablefrench-100x38.jpg 100w\" sizes=\"auto, (max-width: 910px) 100vw, 910px\" \/><\/a><\/p>\n<div class=\"ctfphc-section ctfphc-section-notitle\">Cliquez <a href=\"https:\/\/canadiantaskforce.ca\/wp-content\/uploads\/2016\/09\/ctfphccolorectal-cancerrecommendation-tablefrenchfinal-1.pdf\">ici <\/a>pour voir ce tableau en format PDF.&nbsp;<\/p>\n<hr \/>\n<p>Les ressources, la disponibilit\u00e9 des tests et les pr\u00e9f\u00e9rences du patient doivent \u00eatre prises en compte pour choisir le test de d\u00e9pistage appropri\u00e9.<\/p>\n<hr \/>\n<\/div>\n<section id=\"other-recommendations\" class=\"ctfphc-section\">\n<h3>AUTRES RECOMMANDATIONS<\/h3>\n<section id=\"other-recommendations\" class=\"ctfphc-section\">\n<ul>\n<li><b>Nous recommandons de ne pas utiliser la coloscopie comme test de d\u00e9pistage de premi\u00e8re ligne\u00a0du CCR.<\/b>\n<ul>\n<li>On manque de donn\u00e9es probantes directes de haute qualit\u00e9 sur l\u2019efficacit\u00e9 de la coloscopie en comparaison aux donn\u00e9es de d\u2019autres tests de d\u00e9pistage.<\/li>\n<li>La coloscopie est associ\u00e9e \u00e0 un <strong>plus grand risque d\u2019inconv\u00e9nients<\/strong> (p. ex., saignement mineur, saignement majeur, perforation et d\u00e9c\u00e8s) que les autres tests disponibles.<\/li>\n<li>La r\u00e9alisation d\u2019une coloscopie exige plus de temps et d\u2019expertise ; l\u2019utilisation de la coloscopie pour le d\u00e9pistage r\u00e9duit en outre la disponibilit\u00e9 de ce test pour les personnes souffrant d\u2019une maladie symptomatique (sang visible dans les selles, p. ex.).<\/li>\n<\/ul>\n<\/li>\n<\/ul>\n<\/section>\n<section id=\"implementation-considerations\" class=\"ctfphc-section\">\n<h3>CONSID\u00c9RATIONS SUR LA MISE EN \u0152UVRE<\/h3>\n<ul>\n<li>La RSOS est le test le plus pratique et le plus \u00e9conome en ressources et constituera probablement l\u2019option pr\u00e9f\u00e9r\u00e9e dans la plupart des situations.<\/li>\n<li>Il est important de remarquer que la sigmo\u00efdoscopie flexible peut \u00eatre consid\u00e9r\u00e9e dans des circonstances particuli\u00e8res, en se basant sur les valeurs et pr\u00e9f\u00e9rences du patient (p. ex., r\u00e9ticence \u00e0 l\u2019analyse des selles, pr\u00e9f\u00e9rence pour des tests moins fr\u00e9quents) et sur la disponibilit\u00e9 des ressources.<\/li>\n<\/ul>\n<\/section>\n<section id=\"evidence-summary\" class=\"ctfphc-section\">\n<h3>R\u00c9SUM\u00c9 DES DONN\u00c9ES PROBANTES<\/h3>\n<ul>\n<li>Les donn\u00e9es issues des ERC montrent que le d\u00e9pistage du CCR chez les personnes \u00e2g\u00e9es de 50 \u00e0 74 ans par RSOSg ou sigmo\u00efdoscopie flexible r\u00e9duit l\u2019incidence de CCR de stade avanc\u00e9 et la mortalit\u00e9 li\u00e9e au CCR.<\/li>\n<li>Le TIF est plus sensible que la RSOSg ; les deux tests pr\u00e9sentent une sp\u00e9cificit\u00e9 similaire. Les avantages rapport\u00e9s en mati\u00e8re de mortalit\u00e9 de la RSOSg chez les personnes \u00e2g\u00e9es de 50 \u00e0 74 ans peuvent par cons\u00e9quent \u00eatre g\u00e9n\u00e9ralis\u00e9s au TIF.<\/li>\n<li>Les seuls inconv\u00e9nients directs remarqu\u00e9s tant pour la RSOSg que pour le TIF dans les \u00e9tudes examin\u00e9es \u00e9taient les faux positifs et les faux n\u00e9gatifs.<\/li>\n<li>Les inconv\u00e9nients de la sigmo\u00efdoscopie flexible sont rares, mais comprennent la perforation intestinale, le saignement mineur, le saignement majeur et le d\u00e9c\u00e8s.<\/li>\n<\/ul>\n<\/section>\n<\/section>\n<\/div>\n<\/div><\/div><\/div><\/div>\n","protected":false},"excerpt":{"rendered":"","protected":false},"author":2,"featured_media":8934,"parent":10330,"menu_order":0,"comment_status":"closed","ping_status":"closed","template":"","meta":{"_acf_changed":false,"footnotes":""},"categories":[219,218],"tags":[],"class_list":["post-10201","page","type-page","status-publish","has-post-thumbnail","hentry","category-cancer-colorectal","category-outils"],"acf":[],"_links":{"self":[{"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/pages\/10201","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/pages"}],"about":[{"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/types\/page"}],"author":[{"embeddable":true,"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/comments?post=10201"}],"version-history":[{"count":1,"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/pages\/10201\/revisions"}],"predecessor-version":[{"id":29057,"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/pages\/10201\/revisions\/29057"}],"up":[{"embeddable":true,"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/pages\/10330"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/media\/8934"}],"wp:attachment":[{"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/media?parent=10201"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/categories?post=10201"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/canadiantaskforce.ca\/fr\/wp-json\/wp\/v2\/tags?post=10201"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}